[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352813-105":59,"doc-detail-352813-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-pre-metastatic-niche-mechanisms-heterogeneity-and-therapeutic-opportunities","The pre-metastatic niche - mechanisms, heterogeneity, and therapeutic opportunities","","Metastasis remains the leading cause of cancer-related mortality. The pre-metastatic niche (PMN) provides a framework for understanding how tumors create favorable conditions in distant organs before metastatic colonization. This review maps cellular and molecular hallmarks of PMN, including immune suppression, vascular/lymphatic remodeling, metabolic reprogramming, and stromal reorganization, and follows their spatiotemporal evolution from initiation to colonization. It also evaluates origins of metastatic lesions, emphasizing circulating tumor cells (CTCs), stromal stem-like cells, and extracellular vesicles (EVs). Translational strategies include biomarker development, AI-assisted spatiotemporal profiling, and immune, metabolic, or EV-based interventions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-pre-metastatic-niche-mechanisms-heterogeneity-and-therapeutic-opportunities/352813/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-pre-metastatic-niche-mechanisms-heterogeneity-and-therapeutic-opportunities/352813.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the pre-metastatic niche (PMN) and why does it matter?","Question",{"text":113,"@type":114},"The PMN is a supportive microenvironment in a distant organ remodeled by factors from the primary tumor to facilitate future metastatic colonization. It helps explain how favorable conditions are established before metastasis occurs.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cellular and molecular processes define PMN formation?",{"text":118,"@type":114},"PMN hallmarks include immune suppression, inflammatory signaling, angiogenesis and lymphangiogenesis, organotropism, and metabolic reprogramming, along with stromal reorganization. These features evolve in a coordinated spatiotemporal manner.",{"name":120,"@type":111,"acceptedAnswer":121},"How does this review connect PMN biology to therapeutic opportunities?",{"text":122,"@type":114},"It discusses translational strategies such as biomarker development, spatiotemporal profiling supported by artificial intelligence (AI), and interventions targeting immune, metabolic pathways, or extracellular vesicles (EVs). The goal is early interception and treatment of metastasis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352813,1790196415,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Zhang et al. Molecular Cancer (2026) 25:117 [https://doi.org/10.1186/s12943-026-02645-2](https://doi.org/10.1186/s12943-026-02645-2)  \nMolecular Cancer  \nREVIEW Open Access  \nThe pre-metastatic niche: mechanisms, heterogeneity, and therapeutic opportunities  \nXu-Ran Zhang1,2, Bing Wei1,2*†, Bing-Hua Jiang1,3*† and Wei-Hong Ren4*†  \nAbstract  \nMetastasis remains the leading cause of cancer-related mortality. The concept of the pre-metastatic niche (PMN) has provided a new framework for understanding how tumors establish favorable conditions in distant organs before metastatic colonization. This review delineates the cellular and molecular hallmarks of PMN, including immune suppression, vascular/lymphatic remodeling, metabolic reprogramming, and stromal reorganization, and traces their spatiotemporal evolution from initiation to colonization. It further examines the origins of metastatic lesions, with a focus on circulating tumor cells (CTCs) and stromal stem-like cells, highlights the pivotal role of extracellular vesicles (EVs) in mediating intercellular communication, metabolic reprogramming, and therapeutic applications. Deciphering the immune and stromal determinants of PMN formation offers key mechanistic insight into organ-specific metastasis. Consequently, this review explores translational strategies targeting the PMN, such as biomarker development, spatiotemporal profiling aided by artificial intelligence (AI), and immune, metabolic, or EVbased interventions. Deciphering PMN biology is therefore poised to open new avenues for the early interception and treatment of metastasis.  \nKeywords Pre-metastatic niche, Immune remodeling, Extracellular vesicles, Metabolic reprogramming, Spatiotemporal evolution  \n†Bing Wei, Bing-Hua Jiang and Wei-Hong Ren contributed equally to this work.  \n*Correspondence:  \nBing Wei [zlyyweibing0629@zzu.edu.cn](zlyyweibing0629@zzu.edu.cn)[ ](zlyyweibing0629@zzu.edu.cn)Bing-Hua Jiang [binghjiang@zzu.edu.cn](binghjiang@zzu.edu.cn)[ ](binghjiang@zzu.edu.cn)Wei-Hong Ren [ren_weihong@163.com](ren_weihong@163.com)  \n1The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No.127 DongMing Rd, Zhengzhou, Henan 450008, China 2Henan Key Laboratory of Molecular Pathology, Zhengzhou  \n450008, China  \n3The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450001, China  \n4Department of Clinical Laboratory, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China  \nIntroduction  \nMetastasis, which accounts for nearly 90% of cancerrelated deaths, remains largely refractory to current therapies such as surgery, chemotherapy, targeted therapy, and immunotherapy. This underscores a critical unmet clinical need in the early interception of metastatic spread.  \nHowever, effective strategies to predict and intercept metastasis remain elusive, largely due to the profound heterogeneity of tumors. This heterogeneity arises from variations in primary and metastatic organ sites, as well as individual differences in factors such as disease progression. In theory, tumor cells can reach all organs of the body through the blood circulation, however, successful metastasis and colonization occur only in specific organs, a phenomenon known as organ tropism. This organotropism occurs because metastatic success depends not  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the artic","cbCaihnaw8rP2C4S","https://ap.wps.com/l/cbCaihnaw8rP2C4S","pdf",4423248,33,"English","# Abstract\n# Introduction\n## Metastasis and clinical unmet need\n## Tumor heterogeneity and organ tropism\n## Pre-metastatic niche (PMN) as a receptive microenvironment\n## Key PMN hallmarks and spatiotemporal evolution","[{\"question\":\"What is the pre-metastatic niche (PMN) and why does it matter?\",\"answer\":\"The PMN is a supportive microenvironment in a distant organ remodeled by factors from the primary tumor to facilitate future metastatic colonization. It helps explain how favorable conditions are established before metastasis occurs.\"},{\"question\":\"Which cellular and molecular processes define PMN formation?\",\"answer\":\"PMN hallmarks include immune suppression, inflammatory signaling, angiogenesis and lymphangiogenesis, organotropism, and metabolic reprogramming, along with stromal reorganization. These features evolve in a coordinated spatiotemporal manner.\"},{\"question\":\"How does this review connect PMN biology to therapeutic opportunities?\",\"answer\":\"It discusses translational strategies such as biomarker development, spatiotemporal profiling supported by artificial intelligence (AI), and interventions targeting immune, metabolic pathways, or extracellular vesicles (EVs). The goal is early interception and treatment of metastasis.\"}]","The pre-metastatic niche - mechanisms, heterogeneity, and therapeutic opportunities | PDF",1790101512,83,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82772c7dc26543f18fbec6fa614475fd.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84a7278ed6ecd95402f11a8a1d7ebd3a.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a1f8969259af2b18ed18fa57e7c0929.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32c2b088439821fb1898a73b201a1085.webp",980,1306]